3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
14
Esophageal Neoplasms
5
Adenocarcinoma Of Esophagus
5
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Sarcoma
3
Rectal Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
3
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Multiple Myeloma
2
Kidney Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Renal Cell
2
Breast Carcinoma In Situ
2
Vomiting
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Teratoma
1
Stomach Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Rhabdomyosarcoma
1
Prostate Adenocarcinoma
1
Ovarian Neoplasms
1
Interventions
Doxorubicin
6
pazopanib
5
Gemcitabine
4
pembrolizumab
3
Trabectedin
3
Sorafenib
3
Docetaxel
3
Dacarbazine
3
eribulin
2
Sunitinib
2
Radiotherapy, Conformal
2
Radiotherapy
2
Nivolumab
2
Letrozole
2
Ifosfamide
2
Bevacizumab
2
tremelimumab
1
temsirolimus
1
saracatinib
1
sapanisertib
1
rucaparib
1
romidepsin
1
olaratumab
1
mocetinostat
1
liposomal doxorubicin
1
lenvatinib
1
indolepropanol phosphate
1
durvalumab
1
cixutumumab
1
cabozantinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leiomyosarcoma
×
Neoadjuvant Therapy
×
Clear all
No trials found.